Merck Research Labs
Contemporary Biochemistry
Chris Wiese
Discovery of JANUVIA ™ (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Monday, October 30, 2006 - 3:30pm
Last Updated: Nov 17, 2014 - 1:06 PM
Facebook
LinkedIn
Twitter
YouTube